Taking on type 2: Research Tuesdays
Deadly vascular problems are common for people with type 2 diabetes. In this month’s Research Tuesday’s lecture, the University of Adelaide’s Khalia Primer will talk about her research into finding out the underlying reasons why so many T2D sufferers experience complications.
Although COVID-19 dominates global headlines, here in Australia type 2 diabetes (T2D) remains a far more prevalent threat. Affecting nearly 1 million of us, it’s directly associated with around 9,500 deaths per annum.
We know the vast majority of these lives are lost due to disproportionately high rates of related vascular complications, such as heart attacks, peripheral artery disease and chronic-wound infections. But how and why T2D triggers these complications so frequently has remained a mystery.
Progress, however, is being made. Ongoing research at the University of Adelaide is shining new light on this critical issue and raising hopes for innovative therapy development. This engaging presentation will bring you right up to speed.
Khalia Primer is a University of Adelaide PhD candidate based at the South Australian Health and Medical Research Institute. Her doctoral research focuses on diabetic vascular complications. Ms Primer is also Convenor of the South Australian branch of the Australian Society for Medical Research.
WHAT: Taking on type 2
WHO: Khalia Primer
WHERE: In person at the Braggs Lecture Theatre, University of Adelaide, North Terrace campus. Or register and watch the live Zoom webinar via the Research Tuesdays website or watch the live stream via the Research Tuesdays Facebook page.
WHEN: 5.30–6.30 pm, Tuesday 13 April 2021
COST: Free event
FURTHER INFO: https://www.facebook.com/researchtuesdays/
Khalia Primer, PhD candidate, The University of Adelaide and South Australian Medical and Health Research Institute, Mobile: +61 (0)437 147 809 Email: email@example.com
Crispin Savage, Senior Media and Communications Officer, The University of Adelaide. Mobile: +61 (0)481 912 465, Email: firstname.lastname@example.org